TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells (Q38138901)

29 August 2017

title

TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells (English)

1 reference

29 August 2017

Yoshikane Kikushige

1

1 reference

29 August 2017

Toshihiro Miyamoto

series ordinal

2

1 reference

29 August 2017

publication date

18 September 2013

1 reference

International Journal of Hematology

29 August 2017

published in

1 reference

29 August 2017

volume

98

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

627-633

1 reference

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Clinical studies of acute myeloid leukemia in the Japan Adult Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Remission induction in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Right on target: eradicating leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Restoring function in exhausted CD8 T cells during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Blockade of Tim-3 signaling restores the virus-specific CD8⁺ T-cell response in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Prospective isolation of human clonogenic common myeloid progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Antibodies, Fc receptors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Divergent immunoglobulin g subclass activity through selective Fc receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Ectopic expression of TIM-3 in lung cancers: a potential independent prognostic factor for patients with NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Tim-3 expression in cervical cancer promotes tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Parapharyngeal liposarcoma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1433-6

Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells

21 January 2018

1 reference

12 December 2020

Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia.

1 reference

12 December 2020

Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily

1 reference

12 December 2020

Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

1 reference

12 December 2020

CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice

1 reference

12 December 2020

10.1007/S12185-013-1433-6

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1034721719

0 references

1 reference